Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 275-285 , October 2006

Single-Photon Emission Computed Tomography/Computed Tomography in Lung Cancer and Malignant Lymphoma

  • Orazio Schillaci, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Orazio Schillaci, MD, PhD, Viale Mazzini 121, 00195 Rome, Italy.

References 

  1. Jemal A , Murray T , Ward E , et al.   Cancer statistics, 2005 . CA Cancer J Clin . 2005;55:10–30
  2. Swerdlow AJ . Epidemiology of Hodgkin’s disease and non-Hodgkin’s lymphoma . Eur J Nucl Med Mol Imaging . 2003;30(suppl 1):S3–S12
  3. Buscombe JR , Bombardieri E . Imaging cancer using single photon techniques . Q J Nucl Med Mol Imaging . 2005;49:121–131
  4. Schillaci O , Simonetti G . Fusion imaging in nuclear medicine—applications of dual-modality systems in oncology . Cancer Biother Radiopharm . 2004;19:1–10
  5. Schomacker K , Schicha H . Use of myocardial imaging agents for tumour diagnosis—a success story? . Eur J Nucl Med . 2000;27:1845–1863
  6. Maublant J , Zhang Z , Rapp M , et al.   In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201 . J Nucl Med . 1993;34:1949–1952
  7. Scopinaro F , Schillaci O , Scarpini M , et al.   Technetium-99m sestamibi: an indicator of breast cancer invasiveness . Eur J Nucl Med . 1994;21:984–987
  8. Arbab AS , Koizumi K , Toyama K , et al.   Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines . J Nucl Med . 1996;37:1551–1556
  9. Arbab AS , Koizumi K , Toyama K , et al.   Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line . Nucl Med Commun . 1997;1997:235–240
  10. Hendrikse NH , Franssen EJ , van der Graaf WT , et al.   Visualization of multidrug resistance in vivo . Eur J Nucl Med . 1999;26:283–293
  11. Perek N , Denoyer D . The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detection . Curr Drug Metab . 2002;3:97–113
  12. Edwards CL , Hayes RL . Tumor scanning with 67Ga citrate . J Nucl Med . 1969;10:103–105
  13. Larson SM . Mechanisms of localization of gallium-67 in tumors . Semin Nucl Med . 1978;8:193–203
  14. Nejmeddine F , Caillat-Vigneron N , Escaig F , et al.   Mechanism involved in gallium-67 (Ga-67) uptake by human lymphoid cell lines . Cell Mol Biol . 1998;44:1215–1220
  15. Even-Sapir E , Israel O . Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma . Eur J Nucl Med Mol Imaging . 2003;30(suppl 1):S65–S81
  16. Krenning EP , Kwekkeboom DJ , Bakker WH , et al.   Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and[123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients . Eur J Nucl Med . 1993;20:716–731
  17. Gotthardt M , Behe MP , Alfke H , et al.   Imaging lung tumors with peptide-based radioligands . Clin Lung Cancer . 2003;5:119–124
  18. Machac J , Krynyckyi B , Kim C . Peptide and antibody imaging in lung cancer . Semin Nucl Med . 2002;32:276–292
  19. Samoszuk MK , Anderson AL , Ramzi E , et al.   Radioimmunodetection of Hodgkin’s disease and non-Hodgkin’s lymphomas with monoclonal antibody to eosinophil peroxidase . J Nucl Med . 1993;34:1246–1253
  20. Zuckier LS , DeNardo GL . Trials and tribulations: oncological antibody imaging comes to the fore . Semin Nucl Med . 1997;25:10–29
  21. Maisey MN , Hawkes DJ , Lukswiecki-Vydelingum  . AM synergistic imaging . Eur J Nucl Med . 1992;19:1002–1005
  22. Lucignani G . SPET: sustainable, powerful, effective, timely in vivo molecular imaging . (editorial) Q J Nucl Med Mol Imaging . 2005;49:117–120
  23. Schillaci O . Functional-anatomical image fusion in neuroendocrine tumors . Cancer Biother Radiopharm . 2004;19:129–134
  24. Kramer EL , Noz ME . CT-SPECT fusion for analysis of radiolabeled antibodies: applications in gastrointestinal and lung carcinoma . Nucl Med Biol . 1991;18:27–42
  25. Israel O , Keidar Z , Iosilevsky G , et al.   The fusion of anatomic and physiologic imaging in the management of patients with cancer . Semin Nucl Med . 2001;31:191–205
  26. Shreve PD . Adding structure to function . J Nucl Med . 2000;41:1380–1382
  27. Maintz JB , Viergever MA . A survey of medical imaging registration . Med Image Anal . 1998;2:1–36
  28. Hutton BF , Braun M , Thurfjell L , et al.   Image registration: an essential tool for nuclear medicine . Eur J Nucl Med Mol Imaging . 2002;29:559–577
  29. Pelizzari CA , Chen GT , Spelbring DR , et al.   Accurate registration of CT, PET, and/or MR images of the brain . J Comput Assist Tomogr . 1989;13:20–26
  30. Dayatzikos C . Spatial normalization of 3-D brain images using deformable models . J Comput Assist Tomogr . 1996;20:656–665
  31. Pietrzyk U , Herholz K , Weiss WD . Three-dimensional alignment of functional and morphological tomograms . J Comput Assist Tomogr . 1990;14:51–59
  32. Perault C , Schvartz C , Wampach H , et al.   Thoracic and abdominal SPECT/CT image fusion without external markers in endocrine carcinomas . J Nucl Med . 1997;38:1234–1242
  33. Hawkes DJ . Algorithms for radiological image registration and their clinical applications . J Anat . 1998;193:347–361
  34. Little JA , Hawkes DJ . The registration of multiple medical images acquired from a single subject: why, how, what next? . Stat Methods Med Res . 1997;6:239–265
  35. Treves ST , Mitchell KD , Habboush IH . Three-dimensional image alignment, registration and fusion . Q J Nucl Med . 1998;42:83–92
  36. Audette MA , Ferrie FP , Peters TM . An alghoritmic overview of surface registration techniques for medical imaging . Med Image Anal . 2000;4:201–217
  37. Cook GJR , Ott RJ . Dual-modality imaging . Eur Radiol . 2001;11:1857–1858
  38. von Schulthess GK , Pelc NJ . Integrated-modality imaging: the best of both words . (editorial) Acad Radiol . 2002;9:1241–1244
  39. Bocher M , Balan A , Krausz Y , et al.   Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images . Eur J Nucl Med . 2000;27:619–627
  40. Schillaci O . Hybrid SPECT/CT: a new era for SPECT imaging? . (editorial) Eur J Nucl Med Mol Imaging . 2005;32:521–524
  41. Kneifel S . Radiation dose and radiation protection . In:  von Schulthess GK editors. Clinical Molecular Anatomic Imaging . Philadelphia: Lippincott Williams & Wilkins; 2003;p. 68–71
  42. Katyal S , Kramer EL , Noz ME , et al.   Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer . Cancer Res . 1995;55(suppl):5759s–5763s
  43. Grant SC , Kostakoglu L , Kris MG , et al.   Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial . Eur J Nucl Med . 1996;23:145–149
  44. Schillaci O , Spanu A , Madeddu G . [(99m)Tc]sestamibi and [(99m)Tc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors . Q J Nucl Med Mol Imaging . 2005;49:133–144
  45. Nosotti M , Santambrogio L , Gasparini M , et al.   Role of 99mtc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer . Chest . 2002;122:1361–1364
  46. Schillaci O , Monteleone F , Volpino P , et al.   Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer . Cancer Biother Radiopharm . 1999;14:129–134
  47. Buccheri G , Biggi A , Ferrigno D , et al.   99mTc-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations . Cancer . 2002;94:1796–1807
  48. Spanu A , Ginesu F , Pirica P , et al.   The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions . Int J Oncol . 2003;22:639–649
  49. Kao CH , Wang SJ , Lin WJ , et al.   Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m mathoxy-isobutylisonitrile . Eur J Nucl Med . 1993;20:249–254
  50. Kao CH , ChangLai SP , Shen YY , et al.   Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study . J Nucl Med . 1997;38:1015–1019
  51. Schillaci O , Danieli R , Manni C , et al.   Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? . Nucl Med Commun . 2004;25:705–710
  52. Ost D , Fein AM , Feinsilver SH . Clinical practice (The solitary pulmonary nodule) . N Engl J Med . 2003;348:2535–2542
  53. Minai OA , Raja S , Mehta AC , et al.   Role of Tc-99m MIBI in the evaluation of single pulmonary nodules: a preliminary report . Thorax . 2000;55:60–62
  54. Spanu A , Schillaci O , Ginesu F , et al.   99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation . J Nucl Med . 2004;45:376P; (abstr)
  55. Sergiacomi G , Schillaci O , Leporace M , et al.   Integrated multislice CT and Tc–99m Sestamibi SPECT–CT evaluation of solitary pulmonary nodules . Radiol Med . 2006;111:213–224
  56. Mountain CF . The international system for staging lung cancer . Semin Surg Oncol . 2000;18:106–115
  57. Friedman PJ . Lung cancer staging: efficacy of CT . (editorial) Radiology . 1992;182:307–309
  58. Chiti A , Maffioli LS , Infante M , et al.   Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT . J Nucl Med . 1996;37:938–942
  59. Schillaci O , Spanu A , Scopinaro F , et al.   Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT . J Nucl Med . 2003;44:1219–1224
  60. Shiun SC , Sun SS , Hsu NY , et al.   Detecting mediastinal lymph node metastases in non-small-cell lung cancer using a combination of technetium-99m tetrofosmin chest single photon emission computed tomography and chest computed tomography . Cancer Invest . 2002;20:311–317
  61. Yellin A Zwas ST , Rozenman J , et al.   Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors . Isr Med Assoc J . 2005;712–716 2005 7
  62. Fanti S , Farsad M , Battista G , et al.   Somatostatin receptor scintigraphy for bronchial carcinoid follow-up . Clin Nucl Med . 2003;28:548–552
  63. Musi M , Carbone RG , Bertocchi C , et al.   Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy . Lung Cancer . 1998;22:97–102
  64. Kirsch CM , von Pawel J , Grau I , et al.   Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma . Eur J Nucl Med . 1994;21:1318–1325
  65. Reisenger I , Bohuslavitzki KH , Brenner W , et al.   Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study . J Nucl Med . 1998;39:224–227
  66. Kwekkeboom DJ , Kho GS , Lamberts SWJ , et al.   The value of octreotide scntigraphy in patients with lung cancer . Eur J Nucl Med . 2004;21:1106–1113
  67. Krausz Y , Keidar Z , Kogan I , et al.   SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours . Clin Endocrinol . 2003;59:565–573
  68. Tsagarakis S , Christoforaki M , Giannopoulou H , et al.   A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing’s syndrome . J Clin Endocrinol Metab . 2003;88:4754–4758
  69. Gambhir SS , Shephard JE , Handmaker H , et al.   Analysis of the cost-effectiveness of a somatostatin analog-Tc99m- depreotide (Neotec) in the scintigraphic evaluation of solitary pulmonary nodules . J Nucl Med . 1999;40:57P; (abstr)
  70. Blum J , Handmaker H , Lister-James J , et al.   A multicenter trial with a somatostatin analog Tc-99m depreotide in the evaluation of solitary pulmonary nodules . Chest . 2000;117:1232–1238
  71. Halley A , Hugentobler A , Icard P , et al.   Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules . Eur J Nucl Med Mol Imaging . 2005;32:1026–1032
  72. Danielsson R , Bååth M , Svensson L , et al.   Imaging of regional lymph node metastases with Tc-99m depreotide in patients with lung cancer . Eur J Nucl Med Mol Imaging . 2005;32:925–931
  73. Menda Y , Kahn D . Somatostatin receptor imaging of non-small cell lung cancer with Tc-99m depreotide . Semin Nucl Med . 2002;32:92–96
  74. Israel O , Krausz Y . SPECT/CT in tumour imaging . In:  von Schulthess GK editors. Clinical Molecular Anatomic Imaging . Philadelphia: Lippincott Williams & Wilkins; 2003;p. 447–462
  75. Front D , Israel O , Epelbaum R , et al.   Ga-67 SPECT before and after treatment of lymphoma . Radiology . 1990;175:515–551
  76. Kaplan IL , Swayne LC . Composite gallium SPECT/CT images in the evaluation of recurrent lymphoma . J Nucl Med . 1989;30:874–875 (abstr)
  77. Chajari M , Lacroix J , Peny AM , et al.   Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography? . Eur J Nucl Med . 2002;29:380–387
  78. Israel O , Yefremov N , Mor M , et al.   A new technology of combined transmission (CT) and emission (Ga-67) tomography (TET) in the evaluation of patients with lymphoma . J Nucl Med . 2000;41:70P; (abstr)
  79. Israel O , Yefremov N , Mor M , et al.   Combined transmission Ga-67 emission tomography (TET) in the evaluation of response to treatment and diagnosis of recurrence in patients with lymphoma . Eur J Nucl Med . 2000;27:1160; (abstr)
  80. Sivolella S , Palumbo B , Palumbo I , et al.   Usefulness of SPECT/CT with Ga-67 in evaluating patients with lymphoma . Q J Nucl Med Mol Imaging . 2004;48:34; (abstr)
  81. Palumbo B , Sivolella S , Palumbo I , et al.   67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma . Eur J Nucl Med Mol Imaging . 2005;32:1011–1017
  82. Carrera D , Bajen MT , Mora J , et al.   Clinical utility of fused 67GA SPECT/CT scan images in patients with lymphoma . Rev Esp Med Nucl . 2006;25:3–9 (in Spanish)
  83. Bar-Shalom R . Gallium SPECT/CT in lymphoma: the ups and downs of functional imaging . (editorial) Eur J Nucl Med Mol Imaging . 2005;32:1247–1249
  84. Sopov V , Yuzefovich I , Groshar D , et al.   The effect of attenuation correction on lesion detection in 67Ga SPECT studies . J Nucl Med . 2002;43:102P–103P (abstr)
  85. Ferone D , Semino C , Boschetti M , et al.   Initial staging of lymphoma with octreotide and other receptor imaging agents . Semin Nucl Med . 2005;35:176–185
  86. Erlandsson D , Visvikis D , Waddington WA , et al.   Improved activity quantification with a combined SPECT/CT system . Eur J Nucl Med Mol Imaging . 2002;29:S93; (abstr)
  87. DeNardo GL . Treatment of non-Hodgkin’s lymphoma (NHL) with radiolabeled antibodies (mAbs) . Semin Nucl Med . 2005;35:202–211
  88. Borghaei H , Schilder RJ . Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin) . Semin Nucl Med . 2004;34(suppl 1):4–9
  89. Rao AV , Akabani G , Rizzieri DA . Radioimmunotherapy for non-Hodgkin’s lymphoma . Clin Med Res . 2005;3:157–165
  90. Juweid ME . Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma: from clinical trials to clinical practice . J Nucl Med . 2002;43:1507–1529
  91. Macardle PJ , Nicholson IC . CD20 . J Biol Regul Homeost Agents . 2002;16:136–138
  92. Wiseman GA , Leigh B , Lamonica D , et al.   Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma . Cancer . 2002;94:1349–1357
  93. Boucek J , Turner JH . Validation of prospective whole-body bone marrow dosimetry by SPECT/CT multimodality imaging in 131I-anti-CD20 rituximab radioimmunotherapy of non-Hodgkin’s lymphoma . Eur J Nucl Med Mol Imaging . 2005;32:458–469
  94. Koral KF , Lin S , Fessler JA , et al.   Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphoma . Cancer . 1997;(suppl):2538–2544 15;80
  95. Koral KF , Li J , Dewaraja Y , et al.   I-131 anti-B1 therapy/tracer uptake ratio using a new procedure for fusion of tracer images to computed tomography images . Clin Cancer Res . 1999;5(suppl):3004s–3009s
  96. Koral KF , Dewaraja Y , Li J , et al.   Initial results for Hybrid SPECT–conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma . J Nucl Med . 2000;41:1579–1586
  97. Koral KF , Dewaraja Y , Li J , et al.   Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients . J Nucl Med . 2003;44:457–464

PII: S0001-2998(06)00023-7

doi: 10.1053/j.semnuclmed.2006.05.003

Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 275-285 , October 2006

Article Tools

* Image Usage & Resolution